Translate AMICOR contents if you like

Sunday, June 04, 2017


Quality-By-Design Gets Mixed Reception From Industry
A cursory look at the current status of the FDA’s quality-by-design (QbD) initiative reveals a mixed picture. By mid-2009, early adopters had successfully employed QbD tools to file FDA applications. Other companies cherry-picked the tools while contemplating if and how to expand their piecemeal approaches.

No comments: